(Q35216658)

7 August 2017

title

The principles of molecular therapies for glioblastoma (English)

1 reference

7 August 2017

George Karpati

1

1 reference

7 August 2017

Josephine Nalbantoglu

series ordinal

2

1 reference

7 August 2017

publication date

1 January 2003

1 reference

International Review of Neurobiology

7 August 2017

published in

1 reference

7 August 2017

volume

55

1 reference

7 August 2017

page(s)

151-163

1 reference

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Curing rat glioblastoma: immunotherapy or graft rejection?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

EGFRvIII as a promising target for antibody-based brain tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Adenovirus-mediated p53 gene therapy for human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Reovirus as a novel oncolytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for ch

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Gene therapy of glioblastomas: from suicide to homicide

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Molecular pathogenesis of astrocytoma and glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Molecular pathways in the formation of gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2803%2901006-7

7 January 2021

10.1016/S0074-7742(03)01006-7

Identifiers

DOI

1 reference

7 August 2017

1 reference